Our Mission

Photo courtesy of University of Michigan C.S. Mott Children's HospitalThe primary mission of the Pediatric Early Phase-Clinical Trial Network (PEP-CTN) is to identify and develop effective new agents for children and adolescents with cancer through rational and efficient clinical and laboratory research.

PEP-CTN clinical trials will incorporate correlative genomic, biology, pharmacology, and imaging studies to further the understanding of the disposition and action of new agents introduced into the treatment of children with cancer.

© The Children's Oncology Group
The information and content provided on this website is made available for informational purposes only for children and their families affected by cancer. While the Children's Oncology Group strives to provide accurate and up-to-date information, the information may be out of date or incomplete in certain respects. Please do not rely on this information and seek the care of a qualified medical professional if you have questions regarding a specific medical condition, disease, diagnosis or symptom. The information and content presented herein is not intended to replace the independent clinical judgement, medical advice, screening, health counseling, or other intervention performed by your (or your child's) health care provider. Please contact "911" or your emergency services if this is a health emergency. No endorsement of any specific tests, products, or procedures is made herein.